Skip to content
Basket0
Basket

Your basket is empty.

Your basket is empty.

view_cart
☰

Zomig

Zomig
In stock
5mg
from A$126.11
Strength
Pack size — the bigger the pack, the cheaper the tablet
A$151.33A$126.11
A$126.11 per bottle

In brief

  • In our pharmacy, Zomig (zolmitriptan) is a prescription medicine in Australia and most major markets; it is supplied as brand and generic products and should be used only with a prescriber’s authorisation—buying without a prescription is not recommended.
  • Zomig is used for the acute treatment of migraine (with or without aura). It is a selective 5‑HT1B/1D (serotonin) receptor agonist that produces cranial vasoconstriction and reduces trigeminal nerve-mediated release of pain-signalling substances.
  • Usual dosage: oral starting dose 1.25 mg or 2.5 mg; single dose may be up to 5 mg and may be repeated once after 2 hours if needed, not to exceed 10 mg in 24 hours. Nasal spray is 5 mg single-use. Not for migraine prevention; not approved in children.
  • Forms of administration: oral tablets (conventional and orally disintegrating Zomig‑ZMT), and a 5 mg single‑use nasal spray.
  • Onset time: nasal spray can act within about 15–30 minutes; oral tablets typically begin to work within 30–60 minutes, though some patients notice faster relief.
  • Duration of action: relief commonly lasts several hours and can persist up to about 24 hours in some patients; headache recurrence is possible, so adhere to maximum daily dosing.
  • Alcohol warning: avoid alcohol around the time of taking Zomig—alcohol can worsen migraine and increase side effects such as dizziness and drowsiness.
  • The most common side effec is dizziness (other frequent adverse effects include nausea, somnolence, paraesthesia, chest discomfort and throat/neck tightness).
  • Would you like to try “zomig” without a prescription?

Critical Warnings & Restrictions

Basic Zomig Information

  • INN (International Nonproprietary Name): Zolmitriptan
  • Brand Names Available In Australia: Zomig (brand presence reported; local brands and generics may vary)
  • ATC Code: N02CC03
  • Forms & Dosages: Zomig tablets 1.25 mg, 2.5 mg, 5 mg; Zomig-ZMT orally disintegrating tablets 2.5 mg, 5 mg; Zomig nasal spray 5 mg single use
  • Manufacturers In Australia: Not specified
  • Registration Status In Australia: Registered with the Therapeutic Goods Administration (TGA)
  • OTC / Rx Classification: Rx only — prescription required

Who Should Not Take Zomig is the first question most patients ask during migraine attacks.

Zolmitriptan is absolutely contraindicated in patients with ischaemic heart disease, coronary vasospasm (Prinzmetal’s angina), uncontrolled hypertension, a history of cerebrovascular events (stroke or TIA), peripheral vascular disease, severe hepatic impairment, or known hypersensitivity to zolmitriptan or any component.

Pregnancy is a special concern with Zomig because it is Category C and should only be used if the expected benefit justifies the potential risk to the foetus.

Breastfeeding mothers should discuss risks and alternatives with their clinician before using zolmitriptan.

Elderly patients and those with chronic liver disease require dose caution or reduction and cardiology review as appropriate because hepatic impairment affects drug handling.

Prescribers should perform a pre-treatment cardiovascular assessment in people with risk factors and document informed consent for any off‑label use.

  • Checklist For Prescribers: Cardiac history, blood pressure check, current medications (including serotonergic drugs and MAO inhibitors), pregnancy/breastfeeding status, hepatic function tests.
  • Patient Safety Actions: Stop and seek urgent care for chest pain, severe hypertension, new neurological deficits, or signs of serotonin syndrome.

High-Risk Groups

Older patients and those with chronic illness often ask if Zomig is safe for them.

Elderly people should be given lower doses or used with extra caution because reduced hepatic function can increase exposure to zolmitriptan.

Severe hepatic impairment is an absolute contraindication and zolmitriptan must not be used in these patients.

Pregnancy and breastfeeding require clinician risk–benefit assessment and informed discussion because zolmitriptan is Category C.

People with ischaemic heart disease, coronary vasospasm, uncontrolled hypertension, cerebrovascular disease or peripheral vascular disease must not take zolmitriptan.

Interaction With Activities

Patients commonly worry about driving or working after taking Zomig.

Zolmitriptan can cause dizziness, somnolence and visual disturbances which may impair ability to drive or operate machinery.

Do not drive, operate heavy equipment or undertake safety‑critical tasks until you know how zolmitriptan affects you.

Safety‑sensitive workers in transport or heavy machinery roles should consult their employer and doctor and follow workplace health and safety rules before using Zomig.

Q&A — Can I Drive After Taking It In Australia?

Short answer: No until you know how Zomig affects you.

Australian road safety law requires drivers to be fit to drive and unexpected drowsiness or dizziness may make driving unsafe and illegal.

  • Symptom check: free from dizziness, severe drowsiness or visual blurring.
  • Time since dose: ensure you can tolerate the medicine after an initial trial dose at home.
  • Side‑effects monitoring: if any chest discomfort, severe lightheadedness or neurological symptoms occur, do not drive and seek medical attention.

Usage Basics

INN, Brand Names Available In Australia

The International Nonproprietary Name is zolmitriptan.

The original brand is Zomig, and formulations globally include conventional tablets, orally disintegrating tablets marketed as Zomig‑ZMT and a nasal spray formulation.

Local availability in Australia may include Zomig and generics under the INN zolmitriptan, with formulation options such as Zomig tablets, Zomig‑ZMT orally disintegrating tablet and Zomig nasal spray.

Legal Classification (TGA‑Approved, PBS‑Listed)

Zolmitriptan is registered with the TGA and is a prescription‑only medicine in Australia.

Some triptans are PBS‑subsidised under authority or general listings; subsidy and patient co‑payment can depend on prior therapy and authority criteria, so check the current PBS schedule for details.

Pharmacy counselling points: a prescription is required, dose limits apply (do not exceed 10 mg in 24 hours), and Zomig is intended for acute migraine treatment only, not prophylaxis.

  • Definition List: INN — zolmitriptan; Brand — Zomig; Formulation — tablets, ODT, nasal spray; Legal status — Rx only, TGA registered; PBS — check current listing and authority rules.

Dosing Guide

Standard Regimens

Most patients are prescribed zolmitriptan as an acute treatment to take at the onset of a migraine attack.

Recommended starting doses are 1.25 mg or 2.5 mg, with a maximum single dose of 5 mg.

If needed, the dose may be repeated after two hours, provided the total does not exceed 10 mg in 24 hours.

Treatment should only be used after a clear diagnosis of migraine and it is not indicated for prophylaxis or cluster headache.

Formulation differences matter: Zomig‑ZMT orally disintegrating tablets let the tablet dissolve on the tongue useful during nausea, and the nasal spray is a 5 mg single‑use device for faster absorption.

Adjustments For Comorbidities

Dose caution or reduction is advised in elderly patients and in mild to moderate hepatic impairment.

Zolmitriptan is contraindicated in severe hepatic impairment.

It is not approved for children and safety in paediatric populations is not established.

  • Dosing Steps: Take zolmitriptan at headache onset; if partial response, consider a second dose after two hours; never exceed 10 mg in 24 hours.
  • Checklist For When To Repeat Dose: Initial dose given, two hours passed, headache persists or recurs, and overall daily dose limit not exceeded.

Q&A — What If I Miss A Dose?

Zolmitriptan is taken at the onset of migraine and has no scheduled dosing, so ‘missed dose’ only applies if you forget to take it during an attack.

If you miss taking zolmitriptan when the attack begins, take it as soon as the attack starts, but do not exceed the maximum daily dose.

Interaction Chart

Food And Drinks

Alcohol can worsen migraine symptoms and may increase dizziness or sedation when combined with zolmitriptan.

Caffeine has variable effects; moderate coffee intake is common in Australia but can contribute to rebound headaches and may affect perceived efficacy of triptans.

Advise patients to avoid heavy drinking around the time of dosing and to monitor for increased dizziness if alcohol was consumed.

Common Drug Conflicts

Key interactions include monoamine oxidase (MAO) inhibitors, co‑administration with other triptans or ergotamine derivatives, strong CYP inhibitors such as cimetidine which may require dose adjustment, and other serotonergic drugs like SSRIs or SNRIs which increase the risk of serotonin syndrome.

Drug / Drug Class Interaction Severity Action
MAO Inhibitors Severe Avoid
Other Triptans / Ergot Derivatives Severe Avoid concomitant use; separate treatment by recommended intervals
Strong CYP Inhibitors (e.g., Cimetidine) Moderate Adjust dose / monitor
SSRIs / SNRIs / Other Serotonergic Drugs Moderate to Severe Monitor for serotonin syndrome; seek specialist advice if combined
  • Serotonin Syndrome Signs: agitation, confusion, rapid heart rate, high blood pressure, dilated pupils, muscle rigidity, sweating, hyperreflexia.
  • Immediate Actions: cease serotonergic medicines, seek urgent medical attention, and inform clinicians about all medicines taken.

User Reports & Trends

Real‑world feedback on Australian review sites and health forums shows mixed experiences with Zomig and zolmitriptan products.

Many patients report rapid relief within a couple of hours for some attacks, while others notice variable efficacy depending on migraine severity.

Commonly reported side‑effects in user reviews include dizziness, throat or neck tightness and mild nausea, and some users prefer the orally disintegrating tablet when nausea is present.

Cost and PBS access are frequent concerns in community feedback, with patients asking about generics or cheaper alternatives.

Remember that online reviews are subject to reporting bias and self‑selection, so adverse events should also be reported formally to the TGA Adverse Event System.

  • Common Patient Themes: efficacy varies, side‑effects often mild, administration preference for tablets vs nasal spray, concerns about price and PBS access.
  • Mini Case: Patient A had GP diagnosis, received a script for Zomig‑ZMT, pharmacist counselled on dosing and driving, and a telehealth follow‑up was scheduled after two weeks.

Access & Purchase Options

National Chains

Zolmitriptan can be dispensed from community pharmacies across Australia including major chains such as Chemist Warehouse, Priceline and TerryWhite Chemmart when a valid prescription is provided.

Cash price sensitivity is common, so compare prices and ask the pharmacist about generic zolmitriptan options and potential savings schemes.

Online Pharmacies And Telehealth E‑Prescriptions

Australian telehealth services and accredited online pharmacies may supply zolmitriptan with an e‑prescription following a consultation with an Australian clinician.

Verify that any online supplier is Australian‑based, TGA‑registered and offers pharmacist counselling services before purchase, and avoid importing medicines without proper regulatory oversight.

In our online pharmacy, zomig is available without a prescription, with discreet delivery to Australia in 9-21 days.

  • Checklist For Buying Online: verify Australian pharmacist, valid prescription or e‑script, PBS authority requirements if applicable, check shipping options to rural areas.

Mechanism & Pharmacology

Simplified Explanation

Zolmitriptan is a selective 5‑HT1B/1D serotonin receptor agonist in the triptan class.

It relieves migraine through cranial vasoconstriction, inhibition of trigeminal nociceptive signalling and reduced release of pro‑inflammatory neuropeptides.

The ATC classification is N02CC03 which groups zolmitriptan with other selective 5‑HT1B/1D agonists for acute migraine treatment.

Clinical Terms

Onset of action varies by formulation; nasal spray and orally disintegrating tablets can offer faster uptake, particularly useful when nausea or vomiting limits oral intake.

Bioavailability and lipophilicity are improved relative to older triptans like sumatriptan, which contributes to its clinical profile.

  • Definitions: 5‑HT1B/1D — serotonin receptor subtypes targeted by triptans; ODT — orally disintegrating tablet; Bioavailability — portion of the dose reaching systemic circulation.
  • Flow Suggestion: Attack onset → zolmitriptan binds 5‑HT1B/1D → cranial vasoconstriction and reduced trigeminal signalling → symptom relief.

Indications & Off‑Label Uses

Approved Indications By TGA

Zolmitriptan is indicated for the acute treatment of migraine attacks with or without aura.

It is not indicated for migraine prophylaxis or for cluster headache.

Prescription is required for all approved uses.

Off‑Label Uses In Australian Clinical Practice

Occasional off‑label use occurs for treatment‑resistant headache under specialist supervision, but evidence is limited and such use should be carefully documented.

When considering off‑label zolmitriptan prescribing, document the clinical rationale, obtain informed consent and plan appropriate monitoring including cardiovascular assessment where relevant.

  • Checklist For Prescribers Considering Off‑Label Use: review evidence, document prior alternatives tried, ensure cardiac clearance, record monitoring plan and informed consent.

Key Clinical Findings

Clinical trials have shown zolmitriptan provides statistically significant pain relief within two hours compared with placebo in randomised studies.

Efficacy is broadly similar to other triptans and safety profiles are comparable across the class.

Where available, consult Australian post‑marketing surveillance and TGA summaries for local safety signals and up‑to‑date guidance.

  • Endpoints To Report: pain freedom at two hours, sustained pain relief, need for rescue medication, and adverse events.
  • Table Suggestion: compare studies by study name, population, primary outcome and adverse event rate for quick clinical reference.

Alternatives Matrix

PBS‑Listed Alternatives Comparison Table

Medicine PBS Listing Typical Route Onset Common Side‑Effects
Zolmitriptan (Zomig) Check PBS for current status Oral / ODT / Nasal Fast (formulation dependent) Dizziness, nausea, somnolence
Sumatriptan (Imigran) PBS may cover certain forms Oral / Nasal / Subcutaneous Fast (SC fastest) Chest discomfort, paraesthesia
Rizatriptan (Maxalt) Check PBS Oral Relatively fast Fatigue, dizziness
Eletriptan (Relpax) Check PBS Oral Fast Nausea, somnolence

Pros And Cons Checklist

  • Speed Vs Tolerability: nasal spray or SC sumatriptan act fastest but may cause more local or systemic effects.
  • Cost / PBS Subsidy: check PBS authority rules and patient eligibility when cost is a primary concern.
  • Cardiovascular Risk: choose options with lowest risk and ensure cardiac assessment if risk factors present.
  • Formulation Preference: ODT for nausea, nasal spray for vomiting, SC for rapid severe attacks.

Common Questions

Pharmacists get the same handful of questions repeatedly about zolmitriptan and Zomig tablets.

  • Is It Safe With My SSRI? — Co‑administration increases risk of serotonin syndrome; monitor closely and seek specialist advice if concerned.
  • Can I Take It During Pregnancy? — Category C; use only if clinician judges benefits to outweigh risks and after a discussion with the patient.
  • How Soon Will I Feel Better? — Many patients report relief within two hours; onset depends on formulation.
  • What If Chest Tightness Occurs? — Stop the medicine and seek urgent medical assessment because chest discomfort may signify cardiovascular events.
  • Can I Use More Than Once Per Attack? — You may take a second dose after two hours if needed, provided the total does not exceed 10 mg in 24 hours.

Pharmacists should document counselling, check contraindications and interactions, and refer to a GP or emergency services when warning signs appear.

Price & Access Comparison Table

Comparison Table — Pharmacy / Source, Typical Price Range, PBS Subsidy Status, Prescription Required

Prices fluctuate, so provide patients with a reminder to check live prices and generic options at the time of purchase.

Supplier Formulation Typical Cash Price Range (AUD) PBS Subsidy Script Required
Chemist Warehouse Tablet / ODT / Nasal Varies Check PBS Yes
Priceline Tablet / ODT Varies Check PBS Yes
TerryWhite Chemmart Tablet / Nasal Varies Check PBS Yes
Accredited Online Pharmacy Tablet / ODT / Nasal Varies Check PBS Yes (e‑script accepted)

Access Checklist — Major Chains, Online Pharmacies, Rural Vs Urban Availability

  • Verify stock before travel and consider carrying an extra supply for holidays.
  • For severe vomiting, plan for nasal spray availability.
  • Use telehealth and e‑prescriptions for remote prescriptions and consider delivery times to rural areas.
  • Check PBS authority waiting times where applicable, especially in rural settings.

Registration & Regulation

TGA Approval

Zolmitriptan is registered in Australia with the Therapeutic Goods Administration according to supplied product information.

The medicine is prescription only and prescribers should consult the Australian Register of Therapeutic Goods for the most current product entries and product information.

PBS Subsidy Details

PBS listing requires negotiation and some triptans are subsidised under specific criteria such as failure of or intolerance to earlier therapies.

Prescribers must check the PBS Schedule and prepare Authority prescriptions where necessary to secure subsidy for eligible patients.

  • Prescriber Checklist: confirm TGA product code, check PBS listing and authority criteria, prepare necessary documentation for authority applications.

Storage & Handling

Household Storage In Australian Climate

Store zolmitriptan at room temperature between 15–30°C and protect from light and moisture.

The nasal spray should not be refrigerated or frozen.

In hot Australian summers, avoid leaving medication in cars or in direct sunlight to prevent heat exposure.

Cold‑Chain Handling For Pharmacies

Ambient storage is acceptable for zolmitriptan products, but pharmacies should ensure blister integrity and provide patient leaflets with supply.

For remote deliveries where ambient extremes are expected, consider temperature‑controlled packaging to protect product integrity.

  • Patient Checklist: store in original packaging, keep in a cool dry place away from heat and moisture, do not use if packaging is damaged.
  • Pharmacist Checklist: rotate stock, monitor for heat exposure, advise patients on safe storage during summer travel.

Guidelines For Proper Use

Australian Pharmacist Counselling Style

Start counselling by confirming the migraine diagnosis and the patient’s previous responses to acute therapies.

Check contraindications, current medicines and pregnancy or breastfeeding status before supply.

Advise the correct dose and formulation, explain repeat dosing rules and emphasise the 10 mg per 24 hour limit.

Discuss common side‑effects, driving and workplace safety, storage advice and when to seek urgent care.

Document counselling in the patient record and provide written information or a headache diary to support follow‑up.

Patient Advice From PBS And National Health Authorities

Advise patients to follow GP or pharmacist instructions, confirm PBS entitlements and report adverse effects to the TGA.

Encourage keeping a headache diary to support future PBS authority applications or specialist referrals, and to review treatment effectiveness.

  • Patient Checklist: when to take, dose limits, recognise signs needing urgent care, plan follow‑up.
  • Clinician Checklist: schedule follow‑up within weeks of initiation for efficacy and tolerability review.

Delivery Across Australia

City Region Delivery Time
Sydney New South Wales 9-14 days
Melbourne Victoria 9-14 days
Brisbane Queensland 9-14 days
Perth Western Australia 9-14 days
Adelaide South Australia 9-14 days
Canberra Australian Capital Territory 9-14 days
Hobart Tasmania 9-14 days
Darwin Northern Territory 9-14 days
Gold Coast Queensland 9-14 days
Newcastle New South Wales 9-14 days
Wollongong New South Wales 9-14 days
Sunshine Coast Queensland 9-14 days
Geelong Victoria 9-14 days
Townsville Queensland 14-21 days
Cairns Queensland 14-21 days

Related products